NCT04061044Phase 3Completed

A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert

Study sponsor: Ocular Therapeutix, Inc. · OCUL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-02-10Actual
Enrollment · participants40Actual
Source updated2023-06-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.